Covering both the scientific basis of rheumatology and practical, clinical information for rheumatologists and trainees, Rheumatology, 8th Edition, remains a leading text in this fast-changing field. Dr. Marc Hochberg and his team of worldwide editors and authors keep you abreast of recent advances in the field- all in a user-friendly, accessible manner. Fully updated from cover to cover, this two-volume text is designed to meet the needs of all practicing and academic rheumatologists as well as arthritis-related health care professionals and scientists interested in rheumatic and musculoskeletal diseases.Covers the epidemiology, pathogenesis, clinical manifestations, therapeutic approach, and management of all major as well as rarely encountered rheumatic and musculoskeletal diseases.Discusses clinical examination, imaging principles, differential diagnosis, established and novel therapies, perioperative evaluation, pain management, basic science, and genetics of rheumatic and musculoskeletal diseases.Uses a consistent, logical, reader-friendly format with templated chapters, concise text, and large-scale, state-of-the-art illustrations for efficient visual reference.Contains new chapters covering pre-clinical disease and how to address these patients, common comorbidities in rheumatoid arthritis; emerging therapies for systemic sclerosis; immune mediated complications of checkpoint inhibitors; the epidemiology of COVID-19 and rheumatic and musculoskeletal diseases, emerging treatments for osteoarthritis, and big data analytics.Provides updates to key topics such as systems biology and its impact on our understanding of the pathogenesis of rheumatic and musculoskeletal diseases, the microbiome in rheumatic musculoskeletal diseases, how to manage chronic pain in the patient with a rheumatic disease, drugs and reproductive health, and emerging therapies for patients with RA, SLE, spondyloarthritis, inflammatory muscle disease, and vasculitis.Shares the knowledge and expertise of numerous new contributing authors, as well as new co-editor Dr. Désirée van der Heijde, who is an expert in psoriatic arthritis, spondyloarthritis, imaging, and clinical epidemiology.Provides access to concise videos depicting the use of ultrasound for diagnosis and treatment.Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. If you encounter issues with your eBook please contact Elsevier eBook+ support via textbookscom.support@elsevier.com.

Ankylosing Spondylitis is an inflammatory arthritis that affects the spine and sacroiliac joints as well as other parts of the body, and that can eventually lead, in some patients, to complete fusion of the vertebrae and total rigidity. AS is not a rare health problem, but is in fact found in almost one percent of the US population, typically strikes young people and young families, and in its various forms is probably more common than rheumatoid arthritis.In this invaluable guide, Dr. Michael H. Weisman, one of America's leading authorities on AS, provides a down-to-earth, crystal-clear guide that is ideal for patients and their family. Dr. Weisman explains what AS is, discusses the genetic background to the disease (including the genes that researchers think may predispose some people to AS), explains how to diagnose the disease early and possibly prevent the later development of debilitating rigidity, the use of MRI for early detection, and much more. The book outlines which medications (such as TNF inhibitors) seem the most promising right now, the various drug side effects, the value of physical therapy, other treatment approaches, and whether surgery can be used to manage the complications of the disease. AS can lead to severe disability, but even those who have a milder form will experience painful "flares" alternating with periods of remission. Since it is a progressive disease in many patients, it is very important to reach patients as early as possible. This book will arm patients with the vital information they need to combat the disease. Laurie M. Savage, the Executive Director of the Spondylitis Association of America (SSA), the main patient support group world-wide, has written a foreword to the book. In addition, SSA will endorse the book and their logo will appear on the cover.

Ankylosing Spondylitis is an inflammatory arthritis that affects the spine and sacroiliac joints as well as other parts of the body, and that can eventually lead, in some patients, to complete fusion of the vertebrae and total rigidity. AS is not a rare health problem, but is in fact found in almost one percent of the US population, typically strikes young people and young families, and in its various forms is probably more common than rheumatoid arthritis. In this invaluable guide, Dr. Michael H. Weisman, one of America''s leading authorities on AS, provides a down-to-earth, crystal-clear guide that is ideal for patients and their family. Dr. Weisman explains what AS is, discusses the genetic background to the disease (including the genes that researchers think may predispose some people to AS), explains how to diagnose the disease early and possibly prevent the later development of debilitating rigidity, the use of MRI for early detection, and much more. The book outlines which medications (such as TNF inhibitors) seem the most promising right now, the various drug side effects, the value of physical therapy, other treatment approaches, and whether surgery can be used to manage the complications of the disease. AS can lead to severe disability, but even those who have a milder form will experience painful "flares" alternating with periods of remission. Since it is a progressive disease in many patients, it is very important to reach patients as early as possible. This book will arm patients with the vital information they need to combat the disease. Laurie M. Savage, the Executive Director of the Spondylitis Association of America (SSA), the main patient support group world-wide, has written a foreword to the book. In addition, SSA will endorse the book and their logo will appear on the cover.

Ankylosing Spondylitis is an inflammatory arthritis that affects the spine and sacroiliac joints as well as other parts of the body, and that can eventually lead, in some patients, to complete fusion of the vertebrae and total rigidity. AS is not a rare health problem, but is in fact found in almost one percent of the US population, typically strikes young people and young families, and in its various forms is probably more common than rheumatoid arthritis. In this invaluable guide, Dr. Michael H. Weisman, one of America''s leading authorities on AS, provides a down-to-earth, crystal-clear guide that is ideal for patients and their family. Dr. Weisman explains what AS is, discusses the genetic background to the disease (including the genes that researchers think may predispose some people to AS), explains how to diagnose the disease early and possibly prevent the later development of debilitating rigidity, the use of MRI for early detection, and much more. The book outlines which medications (such as TNF inhibitors) seem the most promising right now, the various drug side effects, the value of physical therapy, other treatment approaches, and whether surgery can be used to manage the complications of the disease. AS can lead to severe disability, but even those who have a milder form will experience painful "flares" alternating with periods of remission. Since it is a progressive disease in many patients, it is very important to reach patients as early as possible. This book will arm patients with the vital information they need to combat the disease. Laurie M. Savage, the Executive Director of the Spondylitis Association of America (SSA), the main patient support group world-wide, has written a foreword to the book. In addition, SSA will endorse the book and their logo will appear on the cover.

Rheumatoid arthritis is a common but often debilitating disorder. Given the intricate and challenging nature of treating rheumatoid arthritis, it is imperative to educate physicians on the disease's initial symptoms and complications, as well as to provide accurate and up-to-date information regarding effective treatment. Designed to help eradicate misconceptions concerning rheumatoid arthritis and its treatment, this concise volume helps clinicians to understand and then effectively diagnose and treat patients with the condition.Part of the Oxford American Rheumatology Library, this concise guide serves as a practical, user-friendly reference for rheumatologists and other healthcare professionals. The book provides an overview of rheumatoid arthritis, including its epidemiology, symptoms, signs, and pathophysiology. Using the most current information available, the author evaluates both traditional and innovative treatment methods. A thorough glossary defines key terms and the appendix includes related resource information - associations, journals and doctors/researchers - all devoted to the study and treatment of rheumatoid arthritis.

Rheumatoid arthritis is a common but often debilitating disorder. Given the intricate and challenging nature of treating rheumatoid arthritis, it is imperative to educate physicians on the disease''s initial symptoms and complications, as well as to provide accurate and up-to-date information regarding effective treatment. Designed to help eradicate misconceptions concerning rheumatoid arthritis and its treatment, this concise volume helps clinicians to understand and then effectively diagnose and treat patients with the condition.Part of the Oxford American Rheumatology Library, this concise guide serves as a practical, user-friendly reference for rheumatologists and other healthcare professionals. The book provides an overview of rheumatoid arthritis, including its epidemiology, symptoms, signs, and pathophysiology. Using the most current information available, the author evaluates both traditional and innovative treatment methods. A thorough glossary defines key terms and the appendix includes related resource information - associations, journals and doctors/researchers - all devoted to the study and treatment of rheumatoid arthritis.

This issue of Rheumatic Disease Clinics, guest edited by Drs. Xenofon Baraliakos and Michael H. Weisman, Spondyloarthritis: The Changing Landscape Today, takes a very comprehensive look at all of the essential topics surrounding spondyloarthritis. This issue is one of four selected each year by Dr. Weisman, who is also our series consulting editor. This very comprehensive issue will include the following topics (among others): Molecular biology approaches to understanding SpA; Microbiome and its role in SpA; Classification criteria in axSpA; Administrative data and coding for axSpA; Approach to the patient with IBD and AxSpA; Axial PsA vs. Axial SpA with Psoriasis; Emerging imaging techniques in SpA; The future of imaging in axSpA; Treatment Recommendations vs. Treat to Target in axSpA; The future of axSpA treatmentAxSpA in the era of Precision Medicine; Quality of Life as an outcome in studies of axSpA; Gender differences in SpA; The patient's perspective on the burden of disease in axSpA; and Juvenile SpA.

This issue of Rheumatic Disease Clinics, guest edited by Drs. Xenofon Baraliakos and Michael H. Weisman, Spondyloarthritis: The Changing Landscape Today, takes a very comprehensive look at all of the essential topics surrounding spondyloarthritis. This issue is one of four selected each year by Dr. Weisman, who is also our series consulting editor. This very comprehensive issue will include the following topics (among others): Molecular biology approaches to understanding SpA; Microbiome and its role in SpA; Classification criteria in axSpA; Administrative data and coding for axSpA; Approach to the patient with IBD and AxSpA; Axial PsA vs. Axial SpA with Psoriasis; Emerging imaging techniques in SpA; The future of imaging in axSpA; Treatment Recommendations vs. Treat to Target in axSpA; The future of axSpA treatmentAxSpA in the era of Precision Medicine; Quality of Life as an outcome in studies of axSpA; Gender differences in SpA; The patient''s perspective on the burden of disease in axSpA; and Juvenile SpA.

Originally published in 2007 and now available for the first time in paperback format, Head and Neck Manifestations of Systemic Disease presents critical information on a multitude of maladies that have manifestations in the head and neck. The book relates commonly encountered head and neck symptoms and signs to an array of diseases and disorders that should be considered in the differential diagnosis. Offering a hands-on approach, this volume addresses specific disease classifications and commonly encountered signs and symptoms in the head and neck region. It offers a clinical approach to disease diagnosis by analyzing the possible causes of a patient's symptoms. The contributors present evidence-based therapeutic options for a variety of conditions, from infections and rheumatologic conditions to hematologic and neoplastic disease. Organized by disease type for easy reference, the book offers a variety of lucid color photographs, providing a unique reference for clinicians who manage diseases with symptoms in this region.

In this special issue of Rheumatic Disease Clinics, guest editor Dr. Michael H. Weisman oversees a unique and celebratory collection of articles honoring The Giants of Rheumatology. Hand-chosen authors in the field celebrate the most influential rheumatologists throughout the years, in commemoration of the 50th volume of Rheumatic Disease Clinics.

Written and edited by international leaders in the field, Rheumatology, 9th Edition, seamlessly blends the latest scientific advances in rheumatology with real-world clinical insights, making it an essential resource for rheumatology specialists and fellows. This comprehensive, two-volume reference uses an easy-to-follow, templated format with concise text and cutting-edge illustrations, covering key topics such as epidemiology, physical examination, pathogenesis, clinical features, therapeutic strategies, and management of both common and rare rheumatic diseases. New contributing authors, new content throughout, and up-to-date coverage of new breakthroughs in the treatment of lupus, rheumatoid arthritis, and more keep you abreast of recent changes in this fast-changing field.

Covering both the scientific basis of rheumatology and practical, clinical information for rheumatologists and trainees, Rheumatology, 8th Edition, remains a leading text in this fast-changing field. Dr. Marc Hochberg and his team of worldwide editors and authors keep you abreast of recent advances in the field- all in a user-friendly, accessible manner. Fully updated from cover to cover, this two-volume text is designed to meet the needs of all practicing and academic rheumatologists as well as arthritis-related health care professionals and scientists interested in rheumatic and musculoskeletal diseases.Covers the epidemiology, pathogenesis, clinical manifestations, therapeutic approach, and management of all major as well as rarely encountered rheumatic and musculoskeletal diseases.Discusses clinical examination, imaging principles, differential diagnosis, established and novel therapies, perioperative evaluation, pain management, basic science, and genetics of rheumatic and musculoskeletal diseases.Uses a consistent, logical, reader-friendly format with templated chapters, concise text, and large-scale, state-of-the-art illustrations for efficient visual reference.Contains new chapters covering pre-clinical disease and how to address these patients, common comorbidities in rheumatoid arthritis; emerging therapies for systemic sclerosis; immune mediated complications of checkpoint inhibitors; the epidemiology of COVID-19 and rheumatic and musculoskeletal diseases, emerging treatments for osteoarthritis, and big data analytics.Provides updates to key topics such as systems biology and its impact on our understanding of the pathogenesis of rheumatic and musculoskeletal diseases, the microbiome in rheumatic musculoskeletal diseases, how to manage chronic pain in the patient with a rheumatic disease, drugs and reproductive health, and emerging therapies for patients with RA, SLE, spondyloarthritis, inflammatory muscle disease, and vasculitis.Shares the knowledge and expertise of numerous new contributing authors, as well as new co-editor Dr. Désirée van der Heijde, who is an expert in psoriatic arthritis, spondyloarthritis, imaging, and clinical epidemiology.Provides access to concise videos depicting the use of ultrasound for diagnosis and treatment.Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. If you encounter issues with your eBook please contact Elsevier eBook+ support via textbookscom.support@elsevier.com.

Ankylosing Spondylitis is an inflammatory arthritis that affects the spine and sacroiliac joints as well as other parts of the body, and that can eventually lead, in some patients, to complete fusion of the vertebrae and total rigidity. AS is not a rare health problem, but is in fact found in almost one percent of the US population, typically strikes young people and young families, and in its various forms is probably more common than rheumatoid arthritis.In this invaluable guide, Dr. Michael H. Weisman, one of America's leading authorities on AS, provides a down-to-earth, crystal-clear guide that is ideal for patients and their family. Dr. Weisman explains what AS is, discusses the genetic background to the disease (including the genes that researchers think may predispose some people to AS), explains how to diagnose the disease early and possibly prevent the later development of debilitating rigidity, the use of MRI for early detection, and much more. The book outlines which medications (such as TNF inhibitors) seem the most promising right now, the various drug side effects, the value of physical therapy, other treatment approaches, and whether surgery can be used to manage the complications of the disease. AS can lead to severe disability, but even those who have a milder form will experience painful "flares" alternating with periods of remission. Since it is a progressive disease in many patients, it is very important to reach patients as early as possible. This book will arm patients with the vital information they need to combat the disease. Laurie M. Savage, the Executive Director of the Spondylitis Association of America (SSA), the main patient support group world-wide, has written a foreword to the book. In addition, SSA will endorse the book and their logo will appear on the cover.

Ankylosing Spondylitis is an inflammatory arthritis that affects the spine and sacroiliac joints as well as other parts of the body, and that can eventually lead, in some patients, to complete fusion of the vertebrae and total rigidity. AS is not a rare health problem, but is in fact found in almost one percent of the US population, typically strikes young people and young families, and in its various forms is probably more common than rheumatoid arthritis. In this invaluable guide, Dr. Michael H. Weisman, one of America''s leading authorities on AS, provides a down-to-earth, crystal-clear guide that is ideal for patients and their family. Dr. Weisman explains what AS is, discusses the genetic background to the disease (including the genes that researchers think may predispose some people to AS), explains how to diagnose the disease early and possibly prevent the later development of debilitating rigidity, the use of MRI for early detection, and much more. The book outlines which medications (such as TNF inhibitors) seem the most promising right now, the various drug side effects, the value of physical therapy, other treatment approaches, and whether surgery can be used to manage the complications of the disease. AS can lead to severe disability, but even those who have a milder form will experience painful "flares" alternating with periods of remission. Since it is a progressive disease in many patients, it is very important to reach patients as early as possible. This book will arm patients with the vital information they need to combat the disease. Laurie M. Savage, the Executive Director of the Spondylitis Association of America (SSA), the main patient support group world-wide, has written a foreword to the book. In addition, SSA will endorse the book and their logo will appear on the cover.

Ankylosing Spondylitis is an inflammatory arthritis that affects the spine and sacroiliac joints as well as other parts of the body, and that can eventually lead, in some patients, to complete fusion of the vertebrae and total rigidity. AS is not a rare health problem, but is in fact found in almost one percent of the US population, typically strikes young people and young families, and in its various forms is probably more common than rheumatoid arthritis. In this invaluable guide, Dr. Michael H. Weisman, one of America''s leading authorities on AS, provides a down-to-earth, crystal-clear guide that is ideal for patients and their family. Dr. Weisman explains what AS is, discusses the genetic background to the disease (including the genes that researchers think may predispose some people to AS), explains how to diagnose the disease early and possibly prevent the later development of debilitating rigidity, the use of MRI for early detection, and much more. The book outlines which medications (such as TNF inhibitors) seem the most promising right now, the various drug side effects, the value of physical therapy, other treatment approaches, and whether surgery can be used to manage the complications of the disease. AS can lead to severe disability, but even those who have a milder form will experience painful "flares" alternating with periods of remission. Since it is a progressive disease in many patients, it is very important to reach patients as early as possible. This book will arm patients with the vital information they need to combat the disease. Laurie M. Savage, the Executive Director of the Spondylitis Association of America (SSA), the main patient support group world-wide, has written a foreword to the book. In addition, SSA will endorse the book and their logo will appear on the cover.

Rheumatoid arthritis is a common but often debilitating disorder. Given the intricate and challenging nature of treating rheumatoid arthritis, it is imperative to educate physicians on the disease's initial symptoms and complications, as well as to provide accurate and up-to-date information regarding effective treatment. Designed to help eradicate misconceptions concerning rheumatoid arthritis and its treatment, this concise volume helps clinicians to understand and then effectively diagnose and treat patients with the condition.Part of the Oxford American Rheumatology Library, this concise guide serves as a practical, user-friendly reference for rheumatologists and other healthcare professionals. The book provides an overview of rheumatoid arthritis, including its epidemiology, symptoms, signs, and pathophysiology. Using the most current information available, the author evaluates both traditional and innovative treatment methods. A thorough glossary defines key terms and the appendix includes related resource information - associations, journals and doctors/researchers - all devoted to the study and treatment of rheumatoid arthritis.

Rheumatoid arthritis is a common but often debilitating disorder. Given the intricate and challenging nature of treating rheumatoid arthritis, it is imperative to educate physicians on the disease''s initial symptoms and complications, as well as to provide accurate and up-to-date information regarding effective treatment. Designed to help eradicate misconceptions concerning rheumatoid arthritis and its treatment, this concise volume helps clinicians to understand and then effectively diagnose and treat patients with the condition.Part of the Oxford American Rheumatology Library, this concise guide serves as a practical, user-friendly reference for rheumatologists and other healthcare professionals. The book provides an overview of rheumatoid arthritis, including its epidemiology, symptoms, signs, and pathophysiology. Using the most current information available, the author evaluates both traditional and innovative treatment methods. A thorough glossary defines key terms and the appendix includes related resource information - associations, journals and doctors/researchers - all devoted to the study and treatment of rheumatoid arthritis.

This issue of Rheumatic Disease Clinics, guest edited by Drs. Xenofon Baraliakos and Michael H. Weisman, Spondyloarthritis: The Changing Landscape Today, takes a very comprehensive look at all of the essential topics surrounding spondyloarthritis. This issue is one of four selected each year by Dr. Weisman, who is also our series consulting editor. This very comprehensive issue will include the following topics (among others): Molecular biology approaches to understanding SpA; Microbiome and its role in SpA; Classification criteria in axSpA; Administrative data and coding for axSpA; Approach to the patient with IBD and AxSpA; Axial PsA vs. Axial SpA with Psoriasis; Emerging imaging techniques in SpA; The future of imaging in axSpA; Treatment Recommendations vs. Treat to Target in axSpA; The future of axSpA treatmentAxSpA in the era of Precision Medicine; Quality of Life as an outcome in studies of axSpA; Gender differences in SpA; The patient's perspective on the burden of disease in axSpA; and Juvenile SpA.

This issue of Rheumatic Disease Clinics, guest edited by Drs. Xenofon Baraliakos and Michael H. Weisman, Spondyloarthritis: The Changing Landscape Today, takes a very comprehensive look at all of the essential topics surrounding spondyloarthritis. This issue is one of four selected each year by Dr. Weisman, who is also our series consulting editor. This very comprehensive issue will include the following topics (among others): Molecular biology approaches to understanding SpA; Microbiome and its role in SpA; Classification criteria in axSpA; Administrative data and coding for axSpA; Approach to the patient with IBD and AxSpA; Axial PsA vs. Axial SpA with Psoriasis; Emerging imaging techniques in SpA; The future of imaging in axSpA; Treatment Recommendations vs. Treat to Target in axSpA; The future of axSpA treatmentAxSpA in the era of Precision Medicine; Quality of Life as an outcome in studies of axSpA; Gender differences in SpA; The patient''s perspective on the burden of disease in axSpA; and Juvenile SpA.

Originally published in 2007 and now available for the first time in paperback format, Head and Neck Manifestations of Systemic Disease presents critical information on a multitude of maladies that have manifestations in the head and neck. The book relates commonly encountered head and neck symptoms and signs to an array of diseases and disorders that should be considered in the differential diagnosis. Offering a hands-on approach, this volume addresses specific disease classifications and commonly encountered signs and symptoms in the head and neck region. It offers a clinical approach to disease diagnosis by analyzing the possible causes of a patient's symptoms. The contributors present evidence-based therapeutic options for a variety of conditions, from infections and rheumatologic conditions to hematologic and neoplastic disease. Organized by disease type for easy reference, the book offers a variety of lucid color photographs, providing a unique reference for clinicians who manage diseases with symptoms in this region.

In this special issue of Rheumatic Disease Clinics, guest editor Dr. Michael H. Weisman oversees a unique and celebratory collection of articles honoring The Giants of Rheumatology. Hand-chosen authors in the field celebrate the most influential rheumatologists throughout the years, in commemoration of the 50th volume of Rheumatic Disease Clinics.

Written and edited by international leaders in the field, Rheumatology, 9th Edition, seamlessly blends the latest scientific advances in rheumatology with real-world clinical insights, making it an essential resource for rheumatology specialists and fellows. This comprehensive, two-volume reference uses an easy-to-follow, templated format with concise text and cutting-edge illustrations, covering key topics such as epidemiology, physical examination, pathogenesis, clinical features, therapeutic strategies, and management of both common and rare rheumatic diseases. New contributing authors, new content throughout, and up-to-date coverage of new breakthroughs in the treatment of lupus, rheumatoid arthritis, and more keep you abreast of recent changes in this fast-changing field.